Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. The Netherlands-based ...

Sage Therapeutics has left its view of Biogen's ... last year's $1.1 billion takeover of immunology player HI-Bio – but does not need to rush into a deal. Biogen has been under pressure from ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

The Master of Science in Medical Research (MEDR) program is designed to help talented students develop strong, well-rounded academic portfolios and become competitive candidates for medical school or ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...

Melanoma is the most aggressive form of skin cancer. Although less common, it is the most serious due to its high potential for metastasis. Despite the health benefits of sunlight, prolonged ...

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer's disease (AD).

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...

Apr. 14, 2025 — Microplastics and the much smaller nanoplastics enter the human body in various ways, for example through food or the air we breathe. A large proportion is excreted, but a ...